{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T03:34:42Z","timestamp":1792812882985,"version":"4.5.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005743","name":"Universit\u00e0 Cattolica del Sacro Cuore","doi-asserted-by":"publisher","award":["R4124500986"],"award-info":[{"award-number":["R4124500986"]}],"id":[{"id":"10.13039\/501100005743","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Neurophysiology"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.clinph.2021.04.019","type":"journal-article","created":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T02:52:00Z","timestamp":1622515920000},"page":"1845-1849","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Cholinergic hyperactivity in patients with myasthenia gravis with MuSK antibodies: A neurophysiological study"],"prefix":"10.1016","volume":"132","author":[{"given":"Anna","family":"Modoni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Mastrorosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregorio","family":"Spagni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelia","family":"Evoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.clinph.2021.04.019_b0005","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1083\/jcb.200307164","article-title":"MuSK is required for anchoring acetylcholinesterase at the neuromuscular junction","volume":"165","author":"Cartaud","year":"2004","journal-title":"J Cell Biol"},{"issue":"2","key":"10.1016\/j.clinph.2021.04.019_b0010","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.pediatrneurol.2012.04.022","article-title":"Neuromuscular junction acetylcholinesterase deficiency responsive to albuterol","volume":"47","author":"Chan","year":"2012","journal-title":"Pediatr Neurol"},{"issue":"20","key":"10.1016\/j.clinph.2021.04.019_b0015","doi-asserted-by":"crossref","first-page":"e2781","DOI":"10.1212\/WNL.0000000000010734","article-title":"Determinants of the repetitive-CMAP occurrence and therapy efficacy in slow-channel myasthenia","volume":"95","author":"Di","year":"2020","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.clinph.2021.04.019_b0020","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/ana.410010403","article-title":"A new myasthenic syndrome with end-plate acetylcholinesterase deficiency, small nerve terminals, and reduced acetylcholine release","volume":"1","author":"Engel","year":"1977","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.clinph.2021.04.019_b0025","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/nyas.13518","article-title":"Myasthenia gravis with antibodies to MuSK: an update","volume":"1412","author":"Evoli","year":"2018","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.clinph.2021.04.019_b0030","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1196\/annals.1405.012","article-title":"Response to therapy in myasthenia gravis with anti-MuSK antibodies","volume":"1132","author":"Evoli","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.clinph.2021.04.019_b0035","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1093\/brain\/awg223","article-title":"Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis","volume":"126","author":"Evoli","year":"2003","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.clinph.2021.04.019_b0040","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.nmd.2013.08.002","article-title":"Salbutamol-responsive limb-girdle congenital myasthenic syndrome due to a novel missense mutation and heteroallelic deletion in MUSK","volume":"24","author":"Gallenm\u00fcller","year":"2014","journal-title":"Neuromuscul Disord"},{"issue":"2","key":"10.1016\/j.clinph.2021.04.019_b0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0087840","article-title":"Effects of the \u00df2-adrenoceptor agonist, albuterol, in a mouse model of anti-MuSK myasthenia gravis","volume":"9","author":"Ghazanfari","year":"2014","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.clinph.2021.04.019_b0050","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.clineuro.2012.06.038","article-title":"Can a rare form of myasthenia gravis shed additional light on disease mechanisms?","volume":"115","author":"Haran","year":"2013","journal-title":"Clin Neurol Neurosurg"},{"issue":"6","key":"10.1016\/j.clinph.2021.04.019_b0055","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1002\/mus.20774","article-title":"Accuracy of repetitive nerve stimulation for diagnosis of the cramp-fasciculation syndrome","volume":"35","author":"Harrison","year":"2007","journal-title":"Muscle Nerve"},{"issue":"9","key":"10.1016\/j.clinph.2021.04.019_b0060","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1212\/01.wnl.0000183145.91579.74","article-title":"Nonresponsiveness to anticholinesterase agents in patients with MuSK-antibody-positive MG","volume":"65","author":"Hatanaka","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.clinph.2021.04.019_b0065","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1093\/brain\/116.3.633","article-title":"Congenital endplate acetylcholinesterase deficiency","volume":"116","author":"Hutchinson","year":"1993","journal-title":"Brain"},{"issue":"9","key":"10.1016\/j.clinph.2021.04.019_b0070","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1093\/brain\/awq213","article-title":"Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia","volume":"133","author":"Irani","year":"2010","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.clinph.2021.04.019_b0075","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1212\/WNL.55.1.16","article-title":"Myasthenia gravis. Recommendations for clinical research standards","volume":"55","author":"Jaretzki","year":"2000","journal-title":"Neurology"},{"issue":"20","key":"10.1016\/j.clinph.2021.04.019_b0080","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1212\/WNL.0b013e318237f660","article-title":"Anti-MuSK autoantibodies block binding of collagen Q to MuSK","volume":"77","author":"Kawakami","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.clinph.2021.04.019_b0085","unstructured":"Kimura J, Electrodiagnosis in disease of Nerve and Muscle: principle and practice. 2001: Oxoford University Press."},{"issue":"3","key":"10.1016\/j.clinph.2021.04.019_b0090","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/mus.23935","article-title":"Cramp-fasciculation syndrome in patients with and without neural autoantibodies","volume":"49","author":"Liewluck","year":"2014","journal-title":"Muscle Nerve"},{"issue":"3","key":"10.1016\/j.clinph.2021.04.019_b0095","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1097\/CND.0000000000000160","article-title":"COLQ-Related Congenital Myasthenic Syndrome and Response to Salbutamol Therapy","volume":"18","author":"Padmanabha","year":"2017","journal-title":"J Clin Neuromuscul Dis"},{"issue":"1","key":"10.1016\/j.clinph.2021.04.019_b0100","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/mus.20515","article-title":"Cholinergic neuromuscular hyperactivity in patients with myasthenia gravis seropositive for MuSK antibody","volume":"34","author":"Punga","year":"2006","journal-title":"Muscle Nerve"},{"issue":"3","key":"10.1016\/j.clinph.2021.04.019_b0105","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/mus.20935","article-title":"Electrophysiological signs and the prevalence of adverse effects of acetylcholinesterase inhibitors in patients with myasthenia gravis","volume":"37","author":"Punga","year":"2008","journal-title":"Muscle Nerve"},{"issue":"2","key":"10.1016\/j.clinph.2021.04.019_b0110","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3988\/jcn.2014.10.2.119","article-title":"Clinical and Electrophysiologic Responses to Acetylcholinesterase Inhibitors in MuSK-Antibody-Positive Myasthenia Gravis: Evidence for Cholinergic Neuromuscular Hyperactivity","volume":"10","author":"Shin","year":"2014","journal-title":"J Clin Neurol"},{"issue":"5","key":"10.1016\/j.clinph.2021.04.019_b0115","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1002\/mus.23907","article-title":"Muscle-specific kinase antibodies: a novel cause of peripheral nerve hyperexcitability?","volume":"48","author":"Simon","year":"2013","journal-title":"Muscle Nerve"},{"issue":"10270","key":"10.1016\/j.clinph.2021.04.019_b0120","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0140-6736(20)32644-1","article-title":"Novichok nerve agent poisoning","volume":"397","author":"Steindl","year":"2021","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.clinph.2021.04.019_b0125","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1002\/(SICI)1097-4598(199609)19:9<1127::AID-MUS7>3.0.CO;2-1","article-title":"Repetitive CMAPs: mechanisms of neural and synaptic genesis","volume":"19","author":"van Dijk","year":"1996","journal-title":"Muscle Nerve"}],"container-title":["Clinical Neurophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388245721005897?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388245721005897?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T12:04:39Z","timestamp":1761393879000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1388245721005897"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":25,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S1388245721005897"],"URL":"https:\/\/doi.org\/10.1016\/j.clinph.2021.04.019","relation":{},"ISSN":["1388-2457"],"issn-type":[{"value":"1388-2457","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cholinergic hyperactivity in patients with myasthenia gravis with MuSK antibodies: A neurophysiological study","name":"articletitle","label":"Article Title"},{"value":"Clinical Neurophysiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinph.2021.04.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 International Federation of Clinical Neurophysiology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}